Menarini-Silicon Biosystems to acquire Cellsearch CTC platform from Janssen Diagnostics

Menarini-Silicon Biosystems has signed an agreement to purchase all assets and business related to the Cellsearch circulating tumor cell system from Janssen Diagnostics for an undisclosed amount. The deal includes a CLIA-certified laboratory in Huntingdon Valley, Pennsylvania.

“Menarini-Silicon Biosystems said today that it has signed an agreement to purchase all the assets and relevant business related to the Cellsearch circulating tumor cell (CTC) system from Janssen Diagnostics for an undisclosed amount.”genomeweb.com

• 1 source
• genomeweb.comMenarini-Silicon Biosystems to Acquire Cellsearch CTC Platform From Janssen Diagnostics | GenomeWebDec 20, 2016

Summarized from public sources; check the original articles before acting on it.